LAROSA JOSEPH J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Tax Payment
Common Stock
2024-12-09$787.00/sh−492$387,204→ 30,777 total - Award
Common Stock
2024-12-06+2,332→ 31,269 total - Award
Non-Qualified Stock Option (right to buy)
2024-12-06+8,981→ 8,981 totalExercise: $771.64Exp: 2034-12-06→ Common Stock (8,981 underlying)
Holdings
- 9,000(indirect: By 2024 GRAT)
Common Stock
- 371(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.